Chair: Steven Julious, Medical Statistics Group, University of Sheffield
Speakers: James Matcham, Amgen and Michael O'Kelly, Senior Director, Quintiles
Making available information from studies sponsored by the pharmaceutical industry: some current practices
Authors: Michael O'Kelly, Steven A. Julious, Stephen Pyke, Simon Day, Sue Todd, Jorgen Seldrup and James Matcham
Pharmaceutical Statistics, Volume 10, Issue 1, pages 60–69 January/February 2011 Abstract | Paper+ | Slides
Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials
Authors: James Matcham, Steven Julious, Stephen Pyke, Michael O'Kelly, Susan Todd, Jorgen Seldrup and Simon Day
Pharmaceutical Statistics, Volume 10, Issue 1, pages 70–73 January/February 2011 Abstract | Paper+ | Slides
The potential for bias in reporting of industry-sponsored clinical trials
Authors: Stephen Pyke, Steven A. Julious, Simon Day, Michael O'Kelly, Susan Todd, James Matcham and Jorgen Seldrup
Pharmaceutical Statistics, Volume 10, Issue 1, pages 74–79 January/February 2011 Abstract | Paper+
Chair: Steven Julious, Medical Statistics Group, University of Sheffield
Speakers: James Matcham, Amgen and Michael O'Kelly, Senior Director, Quintiles
Making available information from studies sponsored by the pharmaceutical industry: some current practices
Authors: Michael O'Kelly, Steven A. Julious, Stephen Pyke, Simon Day, Sue Todd, Jorgen Seldrup and James Matcham
Pharmaceutical Statistics, Volume 10, Issue 1, pages 60–69 January/February 2011 Abstract | Paper+ | Slides
Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials
Authors: James Matcham, Steven Julious, Stephen Pyke, Michael O'Kelly, Susan Todd, Jorgen Seldrup and Simon Day
Pharmaceutical Statistics, Volume 10, Issue 1, pages 70–73 January/February 2011 Abstract | Paper+ | Slides
The potential for bias in reporting of industry-sponsored clinical trials
Authors: Stephen Pyke, Steven A. Julious, Simon Day, Michael O'Kelly, Susan Todd, James Matcham and Jorgen Seldrup
Pharmaceutical Statistics, Volume 10, Issue 1, pages 74–79 January/February 2011 Abstract | Paper+
Chair: Steven Julious, Medical Statistics Group, University of Sheffield
Speakers: James Matcham, Amgen and Michael O'Kelly, Senior Director, Quintiles
Making available information from studies sponsored by the pharmaceutical industry: some current practices
Authors: Michael O'Kelly, Steven A. Julious, Stephen Pyke, Simon Day, Sue Todd, Jorgen Seldrup and James Matcham
Pharmaceutical Statistics, Volume 10, Issue 1, pages 60–69 January/February 2011 Abstract | Paper+ | Slides
Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials
Authors: James Matcham, Steven Julious, Stephen Pyke, Michael O'Kelly, Susan Todd, Jorgen Seldrup and Simon Day
Pharmaceutical Statistics, Volume 10, Issue 1, pages 70–73 January/February 2011 Abstract | Paper+ | Slides
The potential for bias in reporting of industry-sponsored clinical trials
Authors: Stephen Pyke, Steven A. Julious, Simon Day, Michael O'Kelly, Susan Todd, James Matcham and Jorgen Seldrup
Pharmaceutical Statistics, Volume 10, Issue 1, pages 74–79 January/February 2011 Abstract | Paper+
Chair: Steven Julious, Medical Statistics Group, University of Sheffield
Speakers: James Matcham, Amgen and Michael O'Kelly, Senior Director, Quintiles
Making available information from studies sponsored by the pharmaceutical industry: some current practices
Authors: Michael O'Kelly, Steven A. Julious, Stephen Pyke, Simon Day, Sue Todd, Jorgen Seldrup and James Matcham
Pharmaceutical Statistics, Volume 10, Issue 1, pages 60–69 January/February 2011 Abstract | Paper+ | Slides
Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials
Authors: James Matcham, Steven Julious, Stephen Pyke, Michael O'Kelly, Susan Todd, Jorgen Seldrup and Simon Day
Pharmaceutical Statistics, Volume 10, Issue 1, pages 70–73 January/February 2011 Abstract | Paper+ | Slides
The potential for bias in reporting of industry-sponsored clinical trials
Authors: Stephen Pyke, Steven A. Julious, Simon Day, Michael O'Kelly, Susan Todd, James Matcham and Jorgen Seldrup
Pharmaceutical Statistics, Volume 10, Issue 1, pages 74–79 January/February 2011 Abstract | Paper+
Chair: Steven Julious, Medical Statistics Group, University of Sheffield
Speakers: James Matcham, Amgen and Michael O'Kelly, Senior Director, Quintiles
Making available information from studies sponsored by the pharmaceutical industry: some current practices
Authors: Michael O'Kelly, Steven A. Julious, Stephen Pyke, Simon Day, Sue Todd, Jorgen Seldrup and James Matcham
Pharmaceutical Statistics, Volume 10, Issue 1, pages 60–69 January/February 2011 Abstract | Paper+ | Slides
Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials
Authors: James Matcham, Steven Julious, Stephen Pyke, Michael O'Kelly, Susan Todd, Jorgen Seldrup and Simon Day
Pharmaceutical Statistics, Volume 10, Issue 1, pages 70–73 January/February 2011 Abstract | Paper+ | Slides
The potential for bias in reporting of industry-sponsored clinical trials
Authors: Stephen Pyke, Steven A. Julious, Simon Day, Michael O'Kelly, Susan Todd, James Matcham and Jorgen Seldrup
Pharmaceutical Statistics, Volume 10, Issue 1, pages 74–79 January/February 2011 Abstract | Paper+
Chair: Steven Julious, Medical Statistics Group, University of Sheffield
Speakers: James Matcham, Amgen and Michael O'Kelly, Senior Director, Quintiles
Making available information from studies sponsored by the pharmaceutical industry: some current practices
Authors: Michael O'Kelly, Steven A. Julious, Stephen Pyke, Simon Day, Sue Todd, Jorgen Seldrup and James Matcham
Pharmaceutical Statistics, Volume 10, Issue 1, pages 60–69 January/February 2011 Abstract | Paper+ | Slides
Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials
Authors: James Matcham, Steven Julious, Stephen Pyke, Michael O'Kelly, Susan Todd, Jorgen Seldrup and Simon Day
Pharmaceutical Statistics, Volume 10, Issue 1, pages 70–73 January/February 2011 Abstract | Paper+ | Slides
The potential for bias in reporting of industry-sponsored clinical trials
Authors: Stephen Pyke, Steven A. Julious, Simon Day, Michael O'Kelly, Susan Todd, James Matcham and Jorgen Seldrup
Pharmaceutical Statistics, Volume 10, Issue 1, pages 74–79 January/February 2011 Abstract | Paper+
+ Papers available to view from 6th December 2011 to 3rd January 2012.
For a flier advertising the event, please click here.
Upcoming Events
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
PSI Training Course: Regulatory Guidelines for Statisticians
This 2-day course is designed to provide a comprehensive understanding of the regulatory guidelines affecting statisticians in the pharmaceutical industry, including the latest updates in the field. The course will cover key International Council for Harmonisation (ICH) guidelines and other key regional regulatory agency documents.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Efficient R&D: SVEM and Advanced DOE in Preclinical Toxicity Testing
This 1-hour webinar will be an opportunity to hear how JMP have been influential in the toxicity testing of an oncology formulation in a pre-clinical setting. At the end of the presentation there will also be the opportunity to ask questions.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Joint PSI/EFSPI Small Populations & RWD SIG Webinar: Harnessing Real-World Data (RWD) in clinical trials for small populations and rare diseases
In this webinar we will review the range of statistical methodologies used to harness the potential of Real-World Data (RWD) in clinical development, particularly in the context of rare diseases and small populations like paediatrics. The session will include theoretical understanding and practical case studies, with a special focus on Bayesian methods and causal inference.
In this event, we’ll start with a general introduction to hierarchical composite endpoints and an overview of common analysis methods including win ratio, win odds, and net benefit. Then, the practical considerations will be illustrated through case studies from clinical trials in heart failure and chronic kidney disease. We conclude with a discussion and a Q&A.
PSI Training Course: Introduction to Bayesian Methods
This interactive and hands on online course, aimed at beginner Bayesians who have little or no experience in Bayesian statistics, is split into 3 modules. Module 1 introduces Bayesian concepts and looks at how Bayes has been used recently in the Pharmaceutical Industry, and participants will undertake their own data collection exercise in order to analyse a simple Bayesian trial. Module 2 takes a look at the concepts of Bayesian statistics and key terminology and provides a chance to analyse some data using a simple Bayesian approach. Module 3 takes a further look at the use of Bayesian statistics in drug development and regulatory requirements and digs deeper into analysis issues.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Senior Medical Statistician & Statistical Programmer
An exciting opportunity has arisen for a Senior Medical Statistician & Statistical Programmer to join the UKCRC fully registered Derby Clinical Trials Support Unit (Derby CTSU).